We outline the market outlook for genomic profiling in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
What is genomic profiling?
Genomic profiling solutions provide genetic patient data that help physicians determine the appropriate course of treatment. Many solutions in this space also include a software portal that enables physicians to navigate data and make easier, better decisions.
Genomic profiling platforms also allow pharma companies to gather deep data across potential and existing patient populations.
<![endif]-->
<script charset="utf-8" type="text/javascript" src=https://www.cbinsights.com/research/market-trend-report-genomic-profiling-pharma-cro-leaders/"//js.hsforms.net/forms/v2.js">
<script>
hbspt.forms.create({
onFormReady: function ($form) {
window.ClearbitForHubspot.addForm($form);
},
region: "na1",
portalId: "763793",
formId: "90955808-0135-4f5d-b9bc-c9c16290b2f4"
});
</script></div></div></div>"}" data-sheets-userformat="{"2":6657,"3":{"1":0},"12":0,"14":{"1":2,"2":4473924},"15":"Arial"}">FREE DOWNLOAD: THE COMPLETE DIGITAL HEALTH 150 LIST
Features & capabilities
Genomic profiling platforms provide pharma and clinical research organization (CRO) leaders with several capabilities, including the following:
- End-to-end solutions to optimize therapeutic development
- Real-world data to accelerate drug discovery
- Clinical trial patient sequencing
- Companion diagnostic solutions for clinical trial enrollment
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
